MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12933-024-02489-4

Медицинская библиотека · Cardiovascular diabetology · 2024

Metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: risk of heart failure.

Oh Rosa, Kim Gyuri, Lee Kyu-Na, Cho So Hyun, Kim Ji Yoon, Kim Seohyun, Lee You-Bin, Jin Sang-Man, Hur Kyu Yeon, Han Kyungdo, Kim Jae Hyeon

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND AND AIMS: The association between metabolic dysfunction-associated steatotic liver disease (MASLD) and cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM) is unclear. This study aimed to investigate the impact of spectrum of SLD on the risk of heart failure and cardiovascular (CV) mortality in patients with T2DM.

METHODS

In a nationwide cohort study, 2,745,689 adults with T2DM were followed from 2009 to 2012 until 2018. Participants were categorized into no steatotic liver disease (no SLD) and SLD groups. The SLD group was stratified based on metabolic risk factors, alcohol consumption and viral hepatitis. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for heart failure (HF) and CV mortality risk.

RESULTS

The prevalence of MASLD, metabolic alcohol-associated liver disease (MetALD), alcohol-associated liver disease with metabolic dysfunction (ALD with MD) and MASLD with viral hepatitis (VH) was 49.6%, 7.2%, 2.3%, and 2.0%. Individuals with MASLD (adjusted HR [aHR], 1.11), MetALD (aHR, 1.14), ALD with MD (aHR, 1.32) and MASLD with VH (aHR, 1.12) had a higher risk of developing HF compared with the no SLD group. The risk of CV mortality was also increased in those with SLD groups compared to those with no SLD. The risk of new-onset HF and CV mortality showed a J-shaped association with alcohol consumption regardless of SLD status.

CONCLUSION

SLD is independent risk factor of new-onset HF and CV mortality in persons with T2DM, and alcohol consumption has a J-shaped association with risk of HF and CV mortality, regardless of SLD status.

Для цитирования: Oh Rosa, Kim Gyuri, Lee Kyu-Na, Cho So Hyun, Kim Ji Yoon, Kim Seohyun, Lee You-Bin, Jin Sang-Man, Hur Kyu Yeon, Han Kyungdo, Kim Jae Hyeon. Metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: risk of heart failure.. Cardiovascular diabetology. 2024. DOI: 10.1186/s12933-024-02489-4.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.